ELIZABETH SCALZO: Open Payments
NPI 1780283242 · WEST ISLIP, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 19 payments from 10 companies in 2025. Trend: 2023 $818 · 2024 $409 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $220 |
| AstraZeneca Pharmaceuticals LP | 2 | $154 |
| Galvanize Therapeutics, Inc | 1 | $40 |
| Genentech USA, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| PharmaEssentia USA Corporation | 1 | $17 |
| SOBI, INC | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
Products named: KISQALI, IMFINZI, ALIYA SYSTEM, SCEMBLIX, Itovebi, ICLUSIG, Enhertu, BESREMI.
Industry payments across NY — which companies pay providers there.
